Generation and characterization of human Fetal membrane and Decidual cell lines for reproductive biology experiments†.


Journal

Biology of reproduction
ISSN: 1529-7268
Titre abrégé: Biol Reprod
Pays: United States
ID NLM: 0207224

Informations de publication

Date de publication:
19 03 2022
Historique:
received: 08 10 2021
revised: 18 11 2021
accepted: 10 12 2021
pubmed: 23 12 2021
medline: 3 5 2022
entrez: 22 12 2021
Statut: ppublish

Résumé

Human fetal membrane and maternal decidua parietalis form one of the major feto-maternal interfaces during pregnancy. Studies on this feto-maternal interface is limited as several investigators have limited access to the placenta, and experience difficulties to isolate and maintain primary cells. Many cell lines that are currently available do not have the characteristics or properties of their primary cells of origin. Therefore, we created, characterized the immortalized cells from primary isolates from fetal membrane-derived amnion epithelial cells, amnion and chorion mesenchymal cells, chorion trophoblast cells and maternal decidua parietalis cells. Primary cells were isolated from a healthy full-term, not in labor placenta. Primary cells were immortalized using either a HPV16E6E7 retroviral or a SV40T lentiviral system. The immortalized cells were characterized for the morphology, cell type-specific markers, and cell signalling pathway activation. Genomic stability of these cells was tested using RNA seq, karyotyping, and short tandem repeats DNA analysis. Immortalized cells show their characteristic morphology, and express respective epithelial, mesenchymal and decidual markers similar to that of primary cells. Gene expression of immortalized and primary cells were highly correlated (R = 0.798 to R = 0.974). Short tandem repeats DNA analysis showed in the late passage number (>P30) of cell lines matched 84-100% to the early passage number (<P10) of the cell lines revealing there were no genetic drift over the passages. Karyotyping also revealed no chromosomal anomalies. Creation of these cell lines can standardize experimental approaches, eliminate subject to subject variabilities, and benefit the reproductive biological studies on pregnancies by using these cells.

Identifiants

pubmed: 34935931
pii: 6478924
doi: 10.1093/biolre/ioab231
pmc: PMC8934701
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

568-582

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD100729
Pays : United States
Organisme : NCATS NIH HHS
ID : UG3 TR003283
Pays : United States
Organisme : NIH HHS
ID : 5R01HD100729-03
Pays : United States
Organisme : NICHD NIH HHS
ID : 5UG3TR003283-02
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Society for the Study of Reproduction. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Front Physiol. 2020 Jun 30;11:715
pubmed: 32695021
J Clin Invest. 2010 Mar;120(3):803-15
pubmed: 20124728
PLoS One. 2019 Dec 5;14(12):e0226105
pubmed: 31805146
iScience. 2020 Dec 11;24(1):101929
pubmed: 33437932
PLoS One. 2013 Dec 27;8(12):e83416
pubmed: 24386195
J Clin Endocrinol Metab. 2003 Nov;88(11):5564-71
pubmed: 14602805
J Virol. 1993 Apr;67(4):1987-95
pubmed: 8383222
Methods. 2019 Feb 15;155:20-29
pubmed: 30625385
J Matern Fetal Neonatal Med. 2014 Sep;27(13):1320-7
pubmed: 24138141
Placenta. 2020 Nov;101:139-146
pubmed: 32979718
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4382-6
pubmed: 8183918
Mol Hum Reprod. 2016 Feb;22(2):143-57
pubmed: 26690900
Placenta. 2007 Feb-Mar;28(2-3):161-9
pubmed: 16513165
Placenta. 1993 Jul-Aug;14(4):385-406
pubmed: 8248033
Reprod Sci. 2007 Dec;14(8 Suppl):42-5
pubmed: 18089609
Placenta. 2018 Jul;67:15-23
pubmed: 29941169
Obstet Gynecol Clin North Am. 2020 Mar;47(1):147-162
pubmed: 32008665
Immunol Invest. 2011;40(2):183-96
pubmed: 21080833
Placenta. 2016 Aug;44:1-5
pubmed: 27452431
Endocrinology. 2012 Dec;153(12):5993-6002
pubmed: 23125313
Placenta. 2016 Aug;44:69-79
pubmed: 27452440
Int J Mol Sci. 2019 Sep 30;20(19):
pubmed: 31575080
Reprod Sci. 2016 Sep;23(9):1168-78
pubmed: 26919974
J Biol Methods. 2016 May 23;3(2):e41
pubmed: 31453208
Sci Rep. 2017 Oct 13;7(1):13139
pubmed: 29030612
Placenta. 2016 Jun;42:59-73
pubmed: 27238715
Int J Cancer. 2003 Sep 1;106(3):301-9
pubmed: 12845665
Int J Cancer. 2013 Jun 1;132(11):2510-9
pubmed: 23136038
Biol Reprod. 2003 Jul;69(1):331-7
pubmed: 12672669
Am J Reprod Immunol. 2016 May;75(5):505-18
pubmed: 26840942
Placenta. 2008 Mar;29(3):255-65
pubmed: 18272217
Biol Neonate. 2001;79(3-4):163-7
pubmed: 11275645
Aging (Albany NY). 2016 Feb;8(2):216-30
pubmed: 26851389
Reprod Sci. 2007 Dec;14(8 Suppl):35-41
pubmed: 18089608
Exp Cell Res. 1961 Feb;23:14-20
pubmed: 13712490
Infect Immun. 2010 Nov;78(11):4792-9
pubmed: 20805331
Biomech Model Mechanobiol. 2013 Aug;12(4):747-62
pubmed: 22972367
Placenta. 2003 Feb-Mar;24(2-3):173-80
pubmed: 12566244
Am J Obstet Gynecol. 2006 Oct;195(4):998-1003
pubmed: 16893510
Placenta. 2002 Jan;23(1):100-1
pubmed: 11869097
Cell Transplant. 2008 Sep;17(9):1083-1094
pubmed: 28863749
Triangle. 1973;12(4):141-7
pubmed: 4769081
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1261-1269
pubmed: 28388726
Front Physiol. 2020 Jul 24;11:891
pubmed: 32848846
J Biomech Eng. 2014 Nov;136(11):
pubmed: 25171138
Cell Mol Immunol. 2014 Nov;11(6):571-81
pubmed: 24954221
J Virol. 1991 Jan;65(1):473-8
pubmed: 1845902
PLoS One. 2016 Jun 22;11(6):e0157614
pubmed: 27333275
Oncogene. 2010 Jun 10;29(23):3435-45
pubmed: 20383192
Placenta. 2019 Apr;79:40-45
pubmed: 30454905
J Vis Exp. 2018 Apr 30;(134):
pubmed: 29757275
Biol Reprod. 2019 Nov 21;101(5):1018-1030
pubmed: 31292604
Am J Reprod Immunol. 2021 May;85(5):e13368
pubmed: 33145922
Placenta. 2011 Dec;32(12):1016-25
pubmed: 21963187
Cancer Res. 1991 Jan 1;51(1):365-71
pubmed: 1703038
Am J Obstet Gynecol. 2015 Sep;213(3):359.e1-16
pubmed: 26025293
Am J Obstet Gynecol. 2017 Nov;217(5):592.e1-592.e17
pubmed: 28847437
Oncogene. 2005 Nov 21;24(52):7729-45
pubmed: 16299533
J Virol. 1991 Dec;65(12):6872-80
pubmed: 1658380
Lab Chip. 2021 May 18;21(10):1956-1973
pubmed: 34008619
Reprod Sci. 2019 Mar;26(3):394-403
pubmed: 29783884
Sci Signal. 2020 Feb 11;13(618):
pubmed: 32047115
Endocrinology. 1988 Oct;123(4):1771-7
pubmed: 3138102
Placenta. 2019 Apr;79:53-61
pubmed: 30929747
Curr Drug Targets Immune Endocr Metabol Disord. 2003 Mar;3(1):83-92
pubmed: 12570726
Placenta. 2020 Oct;100:122-132
pubmed: 32927240
Placenta. 2020 Sep 15;99:27-34
pubmed: 32750642

Auteurs

Enkhtuya Radnaa (E)

Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynaecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.

Rheanna Urrabaz-Garza (R)

Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynaecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.

Nathan D Elrod (ND)

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555-0144, USA.

Mariana de Castro Silva (M)

Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynaecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.

Richard Pyles (R)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-0144, USA.

Arum Han (A)

Department of Electrical and Computer Engineering, Department of Biomedical Engineering, Texas A&M University, College Station, Texas 77843-3128, USA.

Ramkumar Menon (R)

Division of Maternal-Fetal Medicine and Perinatal Research, Department of Obstetrics and Gynaecology, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH